Floatz logo

Oxycodone

Analgesia

PfizerSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

21 Active assets in the Analgesia cohort.

Asset / SponsorPhaseRating
NEPENTHE
Meri Mirceta
Phase 4BBB
LIDOCAINE
Meri Mirceta
Phase 4BB
ROPIVACAINE
Dr Kassiani Theodoraki
Phase 4BB
DEXAMETHASONE
Meri Mirceta
Phase 4BB
Vts-K
Theresa Jacob, PhD, MPH
Phase 4BB

View all 28 →

Same molecule, other indications

Oxycodone is also rated in:

Low Back PainDormant
BBB
Indicative ·
77 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
osteoarthritisDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →